EU regulation pertaining to good manufacturing practices and environmental risk assessment of pharmaceuticals does not adequately consider the environmental emissions of pharmaceuticals in global manufacturing supply chains, a recent study from the University of Eastern Finland concludes.
Click here for original story, Environmental emissions of pharmaceuticals in global manufacturing supply chains require revised regulations
Source: Phys.org